Brief: Matinas Biopharma Reports Q2 Loss Per Share $0.03

Matinas BioPharma Holdings

10/08/2020 22:36

Aug 10 (Reuters) - Matinas BioPharma Holdings Inc  MTNB.A :
    * MATINAS BIOPHARMA REPORTS SECOND QUARTER 2020 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
    * Q2 LOSS PER SHARE $0.03
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.03 -- REFINITIV IBES
DATA
    * MATINAS BIOPHARMA HOLDINGS- ENHANCE-IT STUDY OF MAT9001
AGAINST
VASCEPA EXPECTED TO BE FULLY ENROLLED IN AUG 2020; TOPLINE DATA
ANTICIPATED Q1 2021
    * MATINAS BIOPHARMA HOLDINGS - ENACT STUDY OF MAT2203 IN
CRYPTOCOCCAL MENINGITIS RESUMED ENROLLMENT; ON TRACK FOR
POTENTIAL COHORT PROGRESSION Q4 2020

Source text for Eikon:  ID:nGNX3sfFny 
Further company coverage:  MTNB.A 

 ((Reuters.Briefs@thomsonreuters.com;))